Researchers at CHAM and the Albert Einstein College of Medicine are working hard to ensure no child is denied a transplant because a donor is not available.  Using novel regimens and alternative graft sources such as related haplo-identical donors (a half match – enabling either parent to become a donor) and combinations of unrelated cord blood with related haplo-identical donors, we are hoping to improve outcomes and open the door to treatment for children who previously had no option. 

We continue to participate in multi-institutional and national clinical trials as well as institutional-based trials. 

The Pediatric Blood and Marrow Transplant Program at CHAM actively participates as a member of the Clinical Trials Network, Pediatric Blood and Marrow Transplant Consortium, Children’s Oncology Group, and Pediatric Acute Lung Injury & Sepsis Investigators – Hematopoietic Stem Cell Transplant sub-group.